Related Experiment Video
Updated: Apr 15, 2026

Genetic Studies of Human DNA Repair Proteins Using Yeast as a Model System
Published on: March 18, 2010
DNA polymerase γ and disease: what we have learned from yeast
Tiziana Lodi1, Cristina Dallabona1, Cecilia Nolli1
1Department of Life Sciences, University of Parma Parma, Italy.
Abstract:
Mip1 is the Saccharomyces cerevisiae DNA polymerase γ (Pol γ), which is responsible for the replication of mitochondrial DNA (mtDNA). It belongs to the family A of the DNA polymerases and it is orthologs to human POLGA. In humans, mutations in POLG(1) cause many mitochondrial pathologies, such as progressive external ophthalmoplegia (PEO), Alpers' syndrome, and ataxia-neuropathy syndrome, all of which present instability of mtDNA, which results in impaired mitochondrial function in several tissues with variable degrees of severity. In this review, we summarize the genetic and biochemical knowledge published on yeast mitochondrial DNA polymerase from 1989, when the MIP1 gene was first cloned, up until now. The role of yeast is particularly emphasized in (i) validating the pathological mutations found in human POLG and modeled in MIP1, (ii) determining the molecular defects caused by these mutations and (iii) finding the correlation between mutations/polymorphisms in POLGA and mtDNA toxicity induced by specific drugs. We also describe recent findings regarding the discovery of molecules able to rescue the phenotypic defects caused by pathological mutations in Mip1, and the construction of a model system in which the human Pol γ holoenzyme is expressed in yeast and complements the loss of Mip1.
Insights
Yeast DNA polymerase γ (Mip1) is a crucial model for studying human mitochondrial diseases. Research validates human POLG mutations in yeast, revealing molecular defects and drug toxicities.
Area of Science:
- Mitochondrial DNA replication
- Molecular genetics
- Yeast as a model organism
Background:
- Mitochondrial DNA polymerase γ (Pol γ) replicates mtDNA.
- Mutations in human POLG cause severe mitochondrial diseases.
- Yeast Mip1 is the ortholog of human POLG.
Purpose of the Study:
- Review genetic and biochemical knowledge of yeast Mip1.
- Utilize yeast to validate human POLG mutations and their effects.
- Explore drug-induced mtDNA toxicity related to POLG polymorphisms.
Main Methods:
- Genetic and biochemical analysis of yeast Mip1.
- Modeling human POLG mutations in the yeast MIP1 gene.
- Developing a yeast system to express human Pol γ holoenzyme.
Main Results:
- Yeast Mip1 serves to validate human POLG mutations.
- Molecular defects caused by POLG mutations are elucidated.
- Correlation between POLGA mutations and drug-induced mtDNA toxicity is established.
Conclusions:
- Yeast Mip1 is a valuable model for human mitochondrial DNA polymerase research.
- Understanding Mip1 function aids in comprehending human mitochondrial pathologies.
- Potential therapeutic strategies for mitochondrial diseases can be explored using this model.
More Related Videos
09:04Studying Ribonucleotide Incorporation: Strand-specific Detection of Ribonucleotides in the Yeast Genome and Measuring Ribonucleotide-induced Mutagenesis
Published on: July 26, 2018
05:37Single-Molecule Fluorescence Visualization of DNA Polymerase Dynamics at G-Quadruplexes
Published on: April 4, 2025
Related Concept Videos
Proofreading
Errors During Replication are Corrected by the DNA Polymerase...
Proofreading
Translesion DNA Polymerases
TLS polymerases are found in all three domains of life - archaea, bacteria, and eukaryotes. Of the different classes of TLS polymerases, members of the Y family are fitted with specialized structures that...
Eukaryotic RNA Polymerases
All three eukaryotic RNAPs require specific transcription factors, of which the...
Eukaryotic RNA Polymerases
Bacterial RNA Polymerase
In most genes, the transcription site is a single base present upstream of the coding sequence. Though RNAP is a catalytically efficient enzyme, it does not recognize...